Search is Powered by Google
IT / Internet / E-mail News

Elsevier Semi-Finalists To Work With 500,000-Plus Articles To Create The Life Sciences Tools Of The Future

Main Category: IT / Internet / E-mail
Also Included In: Biology / Biochemistry
Article Date: 21 Aug 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Elsevier, a leading global healthcare and scientific publisher, has announced ten semi-finalists in The Elsevier Grand Challenge, a competition inviting the scientific community to prototype tools innovating how Life Sciences information is used in online text databases. The ten semifinalists were chosen by a distinguished panel of judges from among over 70 excellent entries offering a range of approaches involving semantics, visualization, protocols, social networks, and citations. The semifinalists include: "We're confident that we've gathered an exciting crop of projects," remarked David Shotton, Image Bioinformatics Research Group, Department of Zoology, University of Oxford, Oxford and Elsevier Challenge Judge, "Some of these very creative ideas will undoubtedly enable scientists to explore, visualize and expose the meaning contained within biological journal articles more thoroughly and effectively, providing better accessibility to the underlying data contained within research papers. This Grand Challenge will give semantic publishing a kick start, to the benefit of everyone's research experience."

Emilie Marcus, Editor-in-Chief, Cell, Cambridge MA, noted, "As one of the judges, I was thrilled and inspired to see such a diverse and creative range of proposals for how to make the daily work of scientists easier and more productive. We await the semi-finalists' presentations in December with bated breath!"

"The semi-finalists will be given access to more than half a million life science articles, including their images and supplementary files in order to build their tool," said Noelle Gracy, Genetics and Cell Biology Publisher and Grand Challenge co-organizer. "Access to such a large and diverse body of work will give them the opportunity to scale up their ideas and really test them to see if they can make something that will change the way life scientists read, write, visualize--even think about--data."

Elsevier Grand Challenge Finalists will be announced at the end of the year will be invited to present vision papers to the judging panel and the public in February 2009. The first place winner will receive a cash prize of $35,000 and the runner up will be awarded a $15,000 prize. Additionally, contestants may be offered the opportunity to develop their tools in collaboration with Elsevier.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

For more information about the awards, visit http://www.elseviergrandchallenge.com/

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Source: Noelle Gracy
Elsevier




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Cholesterol - The Good, The Bad, and Your Diet
Cholesterol - The Good, The Bad, and Your Diet

When it comes to managing cholesterol in your diet, it's important to know what foods can raise and what foods can lower your levels of the bad cholesterol.

more videos are available in our health videos section.